Found: 19
Select item for more details and to access through your institution.
Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.799020
- By:
- Publication type:
- Article
Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.719290
- By:
- Publication type:
- Article
The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0513-y
- By:
- Publication type:
- Article
Metabolically-inactive glucagon-like peptide-1(9--36)amide confers selective protective actions against post-myocardial infarction remodelling.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0386-5
- By:
- Publication type:
- Article
Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
- Published in:
- Diabetes & Vascular Disease Research, 2017, v. 14, n. 5, p. 423, doi. 10.1177/1479164117710390
- By:
- Publication type:
- Article
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 1, p. 212, doi. 10.1093/cvr/cvab043
- By:
- Publication type:
- Article
Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac<sub>2-26</sub>, Against Myocardial Infarction.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00269
- By:
- Publication type:
- Article
Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart.
- Published in:
- Cardiovascular Drugs & Therapy, 2020, v. 34, n. 6, p. 823, doi. 10.1007/s10557-020-07086-7
- By:
- Publication type:
- Article
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
- Published in:
- Cardiovascular Drugs & Therapy, 2019, v. 33, n. 6, p. 669, doi. 10.1007/s10557-019-06914-9
- By:
- Publication type:
- Article
Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes.
- Published in:
- British Journal of Pharmacology, 2015, v. 172, n. 3, p. 721, doi. 10.1111/bph.12943
- By:
- Publication type:
- Article
Characterising an Alternative Murine Model of Diabetic Cardiomyopathy.
- Published in:
- Frontiers in Physiology, 2019, p. 1, doi. 10.3389/fphys.2019.01395
- By:
- Publication type:
- Article
Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy - current and future perspectives.
- Published in:
- Clinical Science, 2021, v. 135, n. 11, p. 1369, doi. 10.1042/CS20210052
- By:
- Publication type:
- Article
Are targeted therapies for diabetic cardiomyopathy on the horizon?
- Published in:
- Clinical Science, 2017, v. 131, n. 10, p. 897, doi. 10.1042/CS20160491
- By:
- Publication type:
- Article
Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy.
- Published in:
- Frontiers in Physiology, 2021, v. 12, p. 1, doi. 10.3389/fphys.2021.672252
- By:
- Publication type:
- Article
Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages.
- Published in:
- Basic Research in Cardiology, 2016, v. 111, n. 1, p. 1, doi. 10.1007/s00395-015-0518-1
- By:
- Publication type:
- Article
Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix
- Published in:
- Basic Research in Cardiology, 2015, v. 110, n. 2, p. 20, doi. 10.1007/s00395-015-0476-7
- By:
- Publication type:
- Article
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications.
- Published in:
- Frontiers in Physiology, 2018, p. 1, doi. 10.3389/fphys.2018.00114
- By:
- Publication type:
- Article